WPI 338 (Diclofenac sodium delayed release 50 mg)

Pill imprint WPI 338 has been identified as Diclofenac sodium delayed release 50 mg.

Diclofenac is used in the treatment of back pain; pain; ankylosing spondylitis; frozen shoulder; muscle pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 50 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WPI 338 (Diclofenac sodium delayed release 50 mg)

Diclofenac sodium delayed release 50 mg WPI 338
Diclofenac sodium delayed release 50 mg WPI 338
Diclofenac sodium delayed release
Imprint:
WPI 338
Strength:
50 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0338

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Got questions about Rheumatoid Arthritis? Get answers from our expert Dr. Carteron. Click Here

Close
Hide
(web4)